Accordingly, the density of tumor-infiltrating T cells (CD45+ CD3+) and CD8+ T cells, measured as number of cells/cm3 of tumor, was significantly increased in the combination therapy group (Figures 6C,D). This evidence concerns the gene PTPRC and neoplasm.